Quote from Top Hair Loss Treatments on June 20, 2019, 2:49 pmAclaris Therapeutics recently published 6 month results of ATI-502 for androgenetic alopecia. ATI-502 is a topically applied JAK inhibitor (more info about JAK inhibitors can be found here).
The key facts from this trial:
The best way to judge how effective this product is is the results photos (attached with this post).
What do you guys think? Will this make it to market? Does it look better than minoxidil?
- 31 subjects (both male and female)
- Target area hair count increased by 5.6 hairs/cm2 in men and 15.3 hairs/cm2 in women
- Investigators rated 73% of subjects as experiencing hair growth
- No serious side effects